179 related articles for article (PubMed ID: 29941342)
1. Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral Sclerosis.
Salter M; Corfield E; Ramadass A; Grand F; Green J; Westra J; Lim CR; Farrimond L; Feneberg E; Scaber J; Thompson A; Ossher L; Turner M; Talbot K; Cudkowicz M; Berry J; Hunter E; Akoulitchev A
EBioMedicine; 2018 Jul; 33():169-184. PubMed ID: 29941342
[TBL] [Abstract][Full Text] [Related]
2. ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia.
Swindell WR; Kruse CPS; List EO; Berryman DE; Kopchick JJ
J Transl Med; 2019 May; 17(1):170. PubMed ID: 31118040
[TBL] [Abstract][Full Text] [Related]
3. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients.
Saucier D; Wajnberg G; Roy J; Beauregard AP; Chacko S; Crapoulet N; Fournier S; Ghosh A; Lewis SM; Marrero A; O'Connell C; Ouellette RJ; Morin PJ
Brain Res; 2019 Apr; 1708():100-108. PubMed ID: 30552897
[TBL] [Abstract][Full Text] [Related]
4. Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis.
Carini C; Hunter E; ; Ramadass AS; Green J; Akoulitchev A; McInnes IB; Goodyear CS
J Transl Med; 2018 Jan; 16(1):18. PubMed ID: 29378619
[TBL] [Abstract][Full Text] [Related]
5. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
[TBL] [Abstract][Full Text] [Related]
6. TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis.
Williams SM; Khan G; Harris BT; Ravits J; Sierks MR
BMC Neurosci; 2017 Jan; 18(1):20. PubMed ID: 28122516
[TBL] [Abstract][Full Text] [Related]
7. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P
JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479
[TBL] [Abstract][Full Text] [Related]
8. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis.
Lu CH; Macdonald-Wallis C; Gray E; Pearce N; Petzold A; Norgren N; Giovannoni G; Fratta P; Sidle K; Fish M; Orrell R; Howard R; Talbot K; Greensmith L; Kuhle J; Turner MR; Malaspina A
Neurology; 2015 Jun; 84(22):2247-57. PubMed ID: 25934855
[TBL] [Abstract][Full Text] [Related]
9. Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS).
Waller R; Goodall EF; Milo M; Cooper-Knock J; Da Costa M; Hobson E; Kazoka M; Wollff H; Heath PR; Shaw PJ; Kirby J
Neurobiol Aging; 2017 Jul; 55():123-131. PubMed ID: 28454844
[TBL] [Abstract][Full Text] [Related]
10. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis.
Feneberg E; Oeckl P; Steinacker P; Verde F; Barro C; Van Damme P; Gray E; Grosskreutz J; Jardel C; Kuhle J; Koerner S; Lamari F; Amador MDM; Mayer B; Morelli C; Muckova P; Petri S; Poesen K; Raaphorst J; Salachas F; Silani V; Stubendorff B; Turner MR; Verbeek MM; Weishaupt JH; Weydt P; Ludolph AC; Otto M
Neurology; 2018 Jan; 90(1):e22-e30. PubMed ID: 29212830
[TBL] [Abstract][Full Text] [Related]
11. Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease.
Abdul Wahid SF; Law ZK; Ismail NA; Lai NM
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011742. PubMed ID: 31853962
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net.
Steinacker P; Huss A; Mayer B; Grehl T; Grosskreutz J; Borck G; Kuhle J; Lulé D; Meyer T; Oeckl P; Petri S; Weishaupt J; Ludolph AC; Otto M
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Feb; 18(1-2):112-119. PubMed ID: 27819158
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study.
Laaksovirta H; Peuralinna T; Schymick JC; Scholz SW; Lai SL; Myllykangas L; Sulkava R; Jansson L; Hernandez DG; Gibbs JR; Nalls MA; Heckerman D; Tienari PJ; Traynor BJ
Lancet Neurol; 2010 Oct; 9(10):978-85. PubMed ID: 20801718
[TBL] [Abstract][Full Text] [Related]
14. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
Conde B; Winck JC; Azevedo LF
Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
[TBL] [Abstract][Full Text] [Related]
15. Human CCS gene: genomic organization and exclusion as a candidate for amyotrophic lateral sclerosis (ALS).
Silahtaroglu AN; Brondum-Nielsen K; Gredal O; Werdelin L; Panas M; Petersen MB; Tommerup N; Tümer Z
BMC Genet; 2002 Apr; 3():5. PubMed ID: 11991808
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
[TBL] [Abstract][Full Text] [Related]
17. A survey of current practice in genetic testing in amyotrophic lateral sclerosis in the UK and Republic of Ireland: implications for future planning.
De Oliveira HM; Soma A; Baker MR; Turner MR; Talbot K; Williams TL
Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; 24(5-6):405-413. PubMed ID: 36458618
[No Abstract] [Full Text] [Related]
18. Mass spectrometry analysis of plasma from amyotrophic lateral sclerosis and control subjects.
Xu Z; Lee A; Nouwens A; Henderson RD; McCombe PA
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):362-376. PubMed ID: 29384411
[TBL] [Abstract][Full Text] [Related]
19. Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics.
Lawton KA; Brown MV; Alexander D; Li Z; Wulff JE; Lawson R; Jaffa M; Milburn MV; Ryals JA; Bowser R; Cudkowicz ME; Berry JD;
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):362-70. PubMed ID: 24984169
[TBL] [Abstract][Full Text] [Related]
20. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.
Verde F; Steinacker P; Weishaupt JH; Kassubek J; Oeckl P; Halbgebauer S; Tumani H; von Arnim CAF; Dorst J; Feneberg E; Mayer B; Müller HP; Gorges M; Rosenbohm A; Volk AE; Silani V; Ludolph AC; Otto M
J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):157-164. PubMed ID: 30309882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
